BBLG Q1 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-30.21

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$928,967

Free Cash Flow

-$928,967

Stock-Based Comp.

$25,724

Balance Sheet

Total Assets

$814,089

Total Liabilities

$11M

Stockholders' Equity

-$10M

Cash & Equivalents

$726,407

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$1M	-8.4%
Net Income	-$1M	-$1M	+3.3%